APB-B002

N/A

Report date: 2025/06/11 11:14:37

Base Information

Drug NameAPB-B002

Drug Alias NameAPB-002APB-B002

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionNeural cell adhesion molecule L1 modulators

TargetsNeural cell adhesion molecule L1

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesApitbio Inc

China Registration ClassN/A

Develop Information

Active CompaniesApitbio Inc

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A